Total Payments
$73,281
2024 Payments
$4,950
Companies
58
Transactions
665
Medicare Patients
5,993
Medicare Billing
$1.3M
Payment Breakdown by Category
Other$44,240 (60.4%)
Food & Beverage$14,560 (19.9%)
Consulting$8,200 (11.2%)
Travel$5,878 (8.0%)
Research$339.08 (0.5%)
Education$63.91 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $44,240 | 18 | 60.4% |
| Food and Beverage | $14,560 | 616 | 19.9% |
| Consulting Fee | $8,200 | 4 | 11.2% |
| Travel and Lodging | $5,878 | 22 | 8.0% |
| Unspecified | $339.08 | 4 | 0.5% |
| Education | $63.91 | 1 | 0.1% |
Payments by Type
General
$72,942
661 transactions
Research
$339.08
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $26,851 | 57 | $0 (2024) |
| Medtronic USA, Inc. | $13,789 | 59 | $0 (2020) |
| Saluda Medical Americas, Inc. | $9,776 | 45 | $0 (2024) |
| Depomed, Inc. | $5,397 | 18 | $0 (2017) |
| Boston Scientific Corporation | $4,468 | 61 | $0 (2024) |
| ASSERTIO THERAPEUTICS, Inc. | $4,251 | 14 | $0 (2019) |
| Vertiflex, Inc. | $1,531 | 17 | $0 (2019) |
| Abbott Laboratories | $969.66 | 42 | $0 (2024) |
| Nevro Corp. | $948.84 | 28 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $840.12 | 55 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,950 | 148 | Boston Scientific Corporation ($2,661) |
| 2023 | $5,378 | 87 | Saluda Medical Americas, Inc. ($3,755) |
| 2022 | $27,467 | 73 | Medtronic, Inc. ($21,576) |
| 2021 | $5,263 | 45 | Medtronic, Inc. ($4,564) |
| 2020 | $12,522 | 51 | Medtronic USA, Inc. ($11,974) |
| 2019 | $4,840 | 83 | Medtronic USA, Inc. ($1,660) |
| 2018 | $5,081 | 68 | Assertio Therapeutics, Inc. ($4,163) |
| 2017 | $7,779 | 110 | Depomed, Inc. ($5,397) |
All Payment Transactions
665 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $44.31 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 12/18/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $19.62 | General |
| Category: Opioid Analgesic | ||||||
| 12/17/2024 | BIOTRONIK NRO, Inc. | Prospera (Device) | Food and Beverage | In-kind items and services | $9.93 | General |
| Category: Not Applicable | ||||||
| 12/17/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $5.05 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/14/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $27.51 | General |
| Category: General - Pain Management_NMD | ||||||
| 12/13/2024 | Medtronic, Inc. | INCEPTIV (Device) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 12/13/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $5.38 | General |
| Category: Spinal Cord Stimulator | ||||||
| 12/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: PAIN | ||||||
| 12/03/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $21.39 | General |
| Category: Opioid Analgesic | ||||||
| 11/27/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $31.40 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/22/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $33.79 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/21/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 11/21/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $4.91 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/21/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $2.44 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/20/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Musculoskeletal | ||||||
| 11/15/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $21.76 | General |
| Category: Opioid Analgesic | ||||||
| 11/14/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $3.92 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/08/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 11/07/2024 | Saluda Medical Americas, Inc. | Evoke (Device) | Food and Beverage | In-kind items and services | $7.83 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/06/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $32.45 | General |
| Category: Neuromodulation | ||||||
| 11/05/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $23.88 | General |
| Category: Opioid Analgesic | ||||||
| 11/04/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 11/01/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Central Nervous System | ||||||
| 10/30/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $1.78 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $11.09 | General |
| Category: WaveWriter Alpha_NMD | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ECAP Study | Saluda Medical Americas, Inc. | $183.86 | 2 |
| Evoke Study | Saluda Medical Americas, Inc. | $155.22 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 1,956 | 16,482 | $1.6M | $433,313 |
| 2022 | 28 | 1,623 | 8,879 | $1.3M | $354,165 |
| 2021 | 27 | 1,426 | 8,750 | $1.1M | $313,668 |
| 2020 | 21 | 988 | 4,147 | $603,322 | $179,532 |
Total Patients
5,993
Total Services
38,258
Medicare Billing
$1.3M
Procedure Codes
128
All Medicare Procedures & Services
128 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 307 | 894 | $161,100 | $87,044 | 54.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 384 | 927 | $119,575 | $63,266 | 52.9% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 29 | 10,326 | $186,000 | $51,231 | 27.5% |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | Office | 2023 | 19 | 2,230 | $44,600 | $22,792 | 51.1% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 129 | 375 | $131,250 | $22,670 | 17.3% |
| 0275T | Removal of bone from lower spine for decompression of nerve tissue using imaging guidance, accessed through the skin | Facility | 2023 | 20 | 21 | $27,300 | $16,356 | 59.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 127 | 127 | $35,025 | $16,199 | 46.3% |
| G3002 | Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan tha | Office | 2023 | 106 | 210 | $26,250 | $13,942 | 53.1% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 50 | 70 | $52,500 | $13,246 | 25.2% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 46 | 54 | $27,000 | $11,206 | 41.5% |
| 62370 | Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | Office | 2023 | 26 | 136 | $54,400 | $10,109 | 18.6% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 45 | 60 | $57,900 | $8,486 | 14.7% |
| 27279 | Fusion of pelvic joint using imaging guidance | Facility | 2023 | 11 | 12 | $12,612 | $8,055 | 63.9% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 50 | 69 | $51,750 | $6,892 | 13.3% |
| 63650 | Insertion of spinal neurostimulator electrode array through skin | Facility | 2023 | 11 | 26 | $84,500 | $6,584 | 7.8% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 36 | 147 | $88,200 | $6,564 | 7.4% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 24 | 31 | $31,000 | $6,200 | 20.0% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2023 | 15 | 40 | $17,800 | $6,054 | 34.0% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 78 | 126 | $37,800 | $5,993 | 15.9% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2023 | 27 | 38 | $28,500 | $5,920 | 20.8% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 19 | 25 | $12,500 | $5,069 | 40.5% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 16 | 40 | $20,000 | $4,959 | 24.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 53 | 53 | $13,700 | $4,763 | 34.8% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 20 | 26 | $26,000 | $4,704 | 18.1% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Office | 2023 | 26 | 36 | $27,000 | $2,899 | 10.7% |
About Todd Bromberg
Todd Bromberg is a Neurology healthcare provider based in Jenkintown, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/19/2007. The National Provider Identifier (NPI) number assigned to this provider is 1174740419.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Todd Bromberg has received a total of $73,281 in payments from pharmaceutical and medical device companies, with $4,950 received in 2024. These payments were reported across 665 transactions from 58 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($44,240).
As a Medicare-enrolled provider, Bromberg has provided services to 5,993 Medicare beneficiaries, totaling 38,258 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 128 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Interventional Pain Medicine
- Location Jenkintown, PA
- Active Since 04/19/2007
- Last Updated 01/11/2013
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1174740419
Products in Payments
- INTELLIS ADAPTIVESTIM (Device) $13,655
- Gralise (Drug) $9,457
- Evoke SCS (Device) $9,217
- VANTA ADAPTIVESTIM (Device) $8,367
- SYNCHROMED (Device) $7,142
- ADAPTIVESTIM (Device) $4,937
- OSTEOCOOL RF ABLATION (Device) $4,410
- SPECTRA WAVEWRITER (Device) $1,605
- Superion ISS (Device) $1,531
- WaveWriter Alpha Prime 16 (Device) $1,523
- LIORESAL (Device) $1,250
- Intracept (Device) $1,069
- Senza Spinal Cord Stimulation System (Device) $527.49
- UBRELVY (Drug) $520.88
- Belbuca (Drug) $463.11
- mild Device Kit (Device) $401.04
- Evoke (Device) $375.37
- XTAMPZA (Drug) $349.85
- Senza (Device) $291.11
- INTELLIS (Device) $290.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.